NO170018C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme substituerte imidazolyl-alkyl-piperazin- og -diazepinderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme substituerte imidazolyl-alkyl-piperazin- og -diazepinderivaterInfo
- Publication number
- NO170018C NO170018C NO881789A NO881789A NO170018C NO 170018 C NO170018 C NO 170018C NO 881789 A NO881789 A NO 881789A NO 881789 A NO881789 A NO 881789A NO 170018 C NO170018 C NO 170018C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- aryl
- piperazine
- substituted imidazolyl
- preparation
- Prior art date
Links
- 150000004908 diazepines Chemical class 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000028867 ischemia Diseases 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 208000022497 Cocaine-Related disease Diseases 0.000 abstract 1
- 206010013654 Drug abuse Diseases 0.000 abstract 1
- 208000005189 Embolism Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 208000020339 Spinal injury Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 201000001272 cocaine abuse Diseases 0.000 abstract 1
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000001037 epileptic effect Effects 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/042,181 US4829065A (en) | 1987-04-24 | 1987-04-24 | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO881789D0 NO881789D0 (no) | 1988-04-22 |
| NO881789L NO881789L (no) | 1988-10-25 |
| NO170018B NO170018B (no) | 1992-05-25 |
| NO170018C true NO170018C (no) | 1992-09-02 |
Family
ID=21920487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO881789A NO170018C (no) | 1987-04-24 | 1988-04-22 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme substituerte imidazolyl-alkyl-piperazin- og -diazepinderivater |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4829065A (de) |
| EP (1) | EP0289227B1 (de) |
| JP (1) | JPH0737451B2 (de) |
| KR (1) | KR960007524B1 (de) |
| AT (1) | ATE74594T1 (de) |
| AU (1) | AU614282B2 (de) |
| CA (1) | CA1320199C (de) |
| DE (1) | DE3869821D1 (de) |
| DK (1) | DK220488A (de) |
| ES (1) | ES2038288T3 (de) |
| FI (1) | FI93104C (de) |
| GR (1) | GR3004317T3 (de) |
| HU (2) | HU199456B (de) |
| IE (1) | IE62106B1 (de) |
| IL (1) | IL86149A (de) |
| MX (1) | MX9203595A (de) |
| NO (1) | NO170018C (de) |
| NZ (1) | NZ224344A (de) |
| PH (1) | PH27325A (de) |
| ZA (1) | ZA882878B (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043447A (en) * | 1987-04-24 | 1991-08-27 | Syntex Pharmaceuticals, Ltd. | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
| US5091428A (en) * | 1987-04-24 | 1992-02-25 | Syntex Pharmaceuticals, Ltd. | Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives |
| US4973591A (en) * | 1988-10-21 | 1990-11-27 | Syntex Pharmaceuticals, Ltd. | Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine |
| US5106845A (en) * | 1990-01-10 | 1992-04-21 | Merrell Dow Pharmaceuticals Inc. | Calcium antagonists |
| US5159083A (en) * | 1990-12-28 | 1992-10-27 | Neurogen Corporation | Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands |
| US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| US5633377A (en) | 1990-12-28 | 1997-05-27 | Neurogen Corporation | 4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands |
| WO1992018089A2 (en) * | 1991-04-09 | 1992-10-29 | The Upjohn Company | Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
| US5633250A (en) * | 1991-12-18 | 1997-05-27 | Schering Corporation | Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms |
| DK0618905T3 (da) * | 1991-12-18 | 1995-12-04 | Schering Corp | Imidazolyl-alkyl-piperazin- og -diazepinderivater som histamin H3-agonister/antagonister |
| US5296609A (en) * | 1993-04-09 | 1994-03-22 | Syntex Pharmaceuticals, Ltd. | Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives |
| US5428037A (en) * | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
| US5478934A (en) * | 1994-11-23 | 1995-12-26 | Yuan; Jun | Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9504662D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| JP2000507579A (ja) * | 1996-04-03 | 2000-06-20 | メルク エンド カンパニー インコーポレーテッド | ファルネシル―タンパク質トランスフェラーゼ阻害剤 |
| US5885995A (en) * | 1996-04-03 | 1999-03-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5869682A (en) * | 1996-04-03 | 1999-02-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5972942A (en) * | 1997-03-27 | 1999-10-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6166205A (en) * | 1998-09-02 | 2000-12-26 | Neurogen Corporation | 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands |
| JP2002540072A (ja) | 1999-03-03 | 2002-11-26 | メルク エンド カムパニー インコーポレーテッド | プレニル蛋白トランスフェラーゼの阻害剤 |
| EP1158983A4 (de) | 1999-03-03 | 2003-05-21 | Merck & Co Inc | Inhibitoren der Prenyl-Protein Transferase |
| EP1165013A4 (de) | 1999-03-03 | 2002-08-07 | Merck & Co Inc | Inhibitoren der phenyl-protein-transferase |
| AU3386600A (en) | 1999-03-03 | 2000-09-21 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| JP2003503482A (ja) * | 1999-07-06 | 2003-01-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | 環化アミノ酸誘導体 |
| SE9904674D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904673D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE0001209D0 (sv) | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| CA2422729A1 (en) * | 2000-09-20 | 2002-06-06 | Schering Corporation | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| PT1395567E (pt) | 2001-05-18 | 2009-03-26 | Astrazeneca Ab | Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais |
| SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203302D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| KR101234421B1 (ko) | 2004-08-02 | 2013-02-18 | 아스트라제네카 아베 | 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도 |
| CN114349745B (zh) * | 2022-01-14 | 2023-12-08 | 黑龙江中医药大学 | 一种用于治疗心肌缺血的药物及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| GB1184714A (en) * | 1965-12-16 | 1970-03-18 | Science Union & Cie | Di- and Tri-Phenylpropyl Piperazine Derivatives |
| US3491098A (en) * | 1967-05-29 | 1970-01-20 | Sterling Drug Inc | 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines |
| DE1795314A1 (de) * | 1968-09-11 | 1972-01-05 | Merck Patent Gmbh | N-(Thiazolyl-2)-piperazine |
| US3927011A (en) * | 1973-05-10 | 1975-12-16 | Yoshitomi Pharmaceutical | 2-Aminoalkyl-1-(pyridylcarbonylphenyl)imidazole compounds |
| IT1056055B (it) * | 1974-03-01 | 1982-01-30 | Malesci Sas Inst Farmaco Bilog | Derivati eterocicli della 4 fenil riperazina i alchil sostituita ad azione farmacologica e relativo procedimento di preparazione |
| US4022783A (en) * | 1975-10-29 | 1977-05-10 | Usv Pharmaceutical Corporation | Piperazinyl-imidazolines |
| GB1551993A (en) * | 1976-09-21 | 1979-09-05 | Malesci Sas | Pharmacologiclly active derivatives of 1 alkyl 4-phenylpiperazines and the preparation thereof |
| IT1159698B (it) * | 1978-05-29 | 1987-03-04 | Rotta Research Lab | Derivati 5-nitro-imidazolici della piperazina ad attivita' antiprotozoica |
| US4243806A (en) * | 1979-06-13 | 1981-01-06 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
| US4404382A (en) * | 1980-09-17 | 1983-09-13 | The Upjohn Company | Piperazinyl-substituted imidazoles |
| CA1162540A (en) * | 1980-12-24 | 1984-02-21 | Ikutaro Saji | Imidazolylpropanol compounds and their acid addition salts, and production and use thereof |
| US4435399A (en) * | 1981-07-18 | 1984-03-06 | Pfizer Inc. | 2-Aryl-1-(imidazol-1-yl)-8-(4-piperazin-1-ylphenoxy) octan-2-ol antifungal agents |
-
1987
- 1987-04-24 US US07/042,181 patent/US4829065A/en not_active Expired - Fee Related
-
1988
- 1988-04-22 FI FI881900A patent/FI93104C/fi not_active IP Right Cessation
- 1988-04-22 IL IL86149A patent/IL86149A/xx not_active IP Right Cessation
- 1988-04-22 ZA ZA882878A patent/ZA882878B/xx unknown
- 1988-04-22 PH PH36835A patent/PH27325A/en unknown
- 1988-04-22 ES ES198888303646T patent/ES2038288T3/es not_active Expired - Lifetime
- 1988-04-22 NZ NZ224344A patent/NZ224344A/xx unknown
- 1988-04-22 HU HU882048A patent/HU199456B/hu not_active IP Right Cessation
- 1988-04-22 JP JP63101194A patent/JPH0737451B2/ja not_active Expired - Lifetime
- 1988-04-22 KR KR1019880004550A patent/KR960007524B1/ko not_active Expired - Fee Related
- 1988-04-22 CA CA000564939A patent/CA1320199C/en not_active Expired - Fee Related
- 1988-04-22 AT AT88303646T patent/ATE74594T1/de active
- 1988-04-22 NO NO881789A patent/NO170018C/no unknown
- 1988-04-22 DK DK220488A patent/DK220488A/da not_active Application Discontinuation
- 1988-04-22 IE IE120988A patent/IE62106B1/en not_active IP Right Cessation
- 1988-04-22 AU AU15102/88A patent/AU614282B2/en not_active Ceased
- 1988-04-22 EP EP88303646A patent/EP0289227B1/de not_active Expired - Lifetime
- 1988-04-22 DE DE8888303646T patent/DE3869821D1/de not_active Expired - Lifetime
-
1992
- 1992-04-09 GR GR910401975T patent/GR3004317T3/el unknown
- 1992-06-26 MX MX9203595A patent/MX9203595A/es unknown
-
1995
- 1995-02-17 HU HU95P/P00079P patent/HU210720A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI93104B (fi) | 1994-11-15 |
| NO170018B (no) | 1992-05-25 |
| HUT46690A (en) | 1988-11-28 |
| DK220488A (da) | 1988-10-25 |
| ATE74594T1 (de) | 1992-04-15 |
| EP0289227B1 (de) | 1992-04-08 |
| FI881900A0 (fi) | 1988-04-22 |
| FI881900A7 (fi) | 1988-10-25 |
| JPS63280081A (ja) | 1988-11-17 |
| KR880012589A (ko) | 1988-11-28 |
| HU210720A9 (en) | 1995-06-28 |
| IE881209L (en) | 1988-10-24 |
| KR960007524B1 (ko) | 1996-06-05 |
| ZA882878B (en) | 1989-12-27 |
| GR3004317T3 (de) | 1993-03-31 |
| EP0289227A1 (de) | 1988-11-02 |
| NO881789L (no) | 1988-10-25 |
| JPH0737451B2 (ja) | 1995-04-26 |
| ES2038288T3 (es) | 1993-07-16 |
| PH27325A (en) | 1993-06-08 |
| HU199456B (en) | 1990-02-28 |
| AU1510288A (en) | 1988-10-27 |
| CA1320199C (en) | 1993-07-13 |
| AU614282B2 (en) | 1991-08-29 |
| IL86149A (en) | 1993-01-14 |
| NZ224344A (en) | 1991-01-29 |
| IL86149A0 (en) | 1988-11-15 |
| IE62106B1 (en) | 1994-12-14 |
| US4829065A (en) | 1989-05-09 |
| DK220488D0 (da) | 1988-04-22 |
| MX9203595A (es) | 1992-09-01 |
| FI93104C (fi) | 1995-02-27 |
| NO881789D0 (no) | 1988-04-22 |
| DE3869821D1 (de) | 1992-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO170018C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme substituerte imidazolyl-alkyl-piperazin- og -diazepinderivater | |
| NO173651C (no) | Analogifremgnagsmaate ved fremstilling av terapeutisk aktive benzodiazepinanaloger | |
| EP1016664A4 (de) | Kondensierte thiophenderivate und ihre medizinische anwendung | |
| IL96498A0 (en) | Aminocarbonylcarbamates related to physostigmine,a process for their preparation and their use as medicaments | |
| ATE167861T1 (de) | 1,2,4-oxadiazolyl oder 1,2,4-thiadiazolyl- derivate als angiotensin ii antagonisten | |
| ATE101147T1 (de) | Pharmazeutisch verwendbare polymorphe modifikation von buspiron. | |
| PT98773A (pt) | Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem | |
| PT92234A (pt) | Processo para a preparacao de 1,2,3,4-tetraidro-1,9-acridinodiaminas | |
| NO180303C (no) | Kondenserte diazepinoner, og midler som inneholder disse forbindelser | |
| NO892152D0 (no) | Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem. | |
| FI96308C (fi) | Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi | |
| ATE113950T1 (de) | 4,5,6,11-tetrahydrobenzo(6,7>-cycloocta(1,2- b>thiophen-6,11-imine und 6,11-dihydrobenzo(6,7>- cycloocta(1,2-b>thiophen-6,11-imine. | |
| ES501744A0 (es) | Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas | |
| MX9100640A (es) | Carbamoil-1-(piridinilalquil)-1h-indoles,indolinas y analogos a fines |